Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature.

We were unable to identify any substantial risk for developing melanoma due to the use of anti-psoriatic treatments. Until additional long-term registry data become available, it would be prudent to continue screening patients with psoriasis at baseline and periodically for melanoma when these agents are used.